株式会社HIROTSUバイオサイエンス
Tokyo, JP · 1 known investors
HIROTSUS Bioscience develops N-NOSE, a cancer screening test that uses nematodes to detect trace odor markers in urine samples, enabling early cancer detection. The company operates in medical diagnostics and contributes to public health through research and development.
Founders & leadership
広
広津崇亮
Investors · 1
Frequently asked questions
- What does 株式会社HIROTSUバイオサイエンス do?
- HIROTSUS Bioscience develops N-NOSE, a cancer screening test that uses nematodes to detect trace odor markers in urine samples, enabling early cancer detection. The company operates in medical diagnostics and contributes to public health through research and development.
- Who founded 株式会社HIROTSUバイオサイエンス?
- 株式会社HIROTSUバイオサイエンス was founded by 広津崇亮.
- Who are 株式会社HIROTSUバイオサイエンス's investors?
- 株式会社HIROTSUバイオサイエンス's investors include Iyogin Capital.
- Where is 株式会社HIROTSUバイオサイエンス headquartered?
- 株式会社HIROTSUバイオサイエンス is headquartered in Tokyo, JP.